Effectiveness of Conservative Treatment in Patients With Thoracic and Lumbar Fractures Without Neurological Deficit
NCT ID: NCT06059820
Last Updated: 2025-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2023-11-01
2025-09-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age Patient
NCT06591442
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
NCT02387905
Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression
NCT00634426
Percutaneous Vertebroplasty Versus Conservative Treatment of Pain
NCT00203554
Minimally Invasive Decompression and Fusion Versus Open for Degenerative Lumbar Stenosis
NCT04594980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* to conduct a retrospective analysis of the surgical treatment outcomes in patients with thoracic or lumbar vertebral fractures;
* to assess the immediate and long-term outcomes of conservative therapy in patients with thoracic or lumbar vertebral injuries;
* to evaluate the overall cost of surgical and conservative treatment one year post-discharge, as well as the duration of disability in patients with thoracic or lumbar vertebral fractures;
* to compare the results of surgical and conservative treatment methods in patients with thoracic or lumbar vertebral fractures.
The research focus will be on patients diagnosed with uncomplicated fractures of the thoracic and lumbar spine, classified as type A2 and A3 according to the AOSpine classification.
Two patient groups will be formed:
The main group (prospective) will consist of patients who underwent conservative therapy. The expected number of observations in the main group will be 40 patients.
The control group (historical control) will be comprised of 40 patients who underwent surgery previously at the Sklifosovsky Research Institute for Emergency Medicine.
The first stage of conservative therapy will be administered within 7 days at the departments of the Sklifosovsky Research Institute for Emergency Medicine. Subsequently, the patient will be transferred to a rehabilitation center for the second stage of conservative treatment at Branch No. 3 of the State Autonomous Healthcare Institution "Moscow Scientific and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine". The third stage of medical rehabilitation will be carried out at outpatient healthcare facilities based on the patient's place of residence.
The study will be considered complete when the data from the final examination of at least 50 patients in each group have been analyzed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conservative treatment group
The main group (prospective) will consist of patients who received conservative therapy. The expected number of observations in the main group will be 50 patients.
rehabilitation treatment
3-month immobilization period, hyperextension braces for specific fractures, therapeutic exercises, and gradual activity restoration.
Surgical treatment group
The control group (historical control) will be comprised of 50 patients who underwent surgery previously at the Sklifosovsky Research Institute for Emergency Medicine.
Spine fusion
Pedicle screw fixation or fusion; anterior plate fusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rehabilitation treatment
3-month immobilization period, hyperextension braces for specific fractures, therapeutic exercises, and gradual activity restoration.
Spine fusion
Pedicle screw fixation or fusion; anterior plate fusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Isolated fracture of a single thoracic or lumbar vertebra, classified as type A2 or A3 according to the AOSpine classification.
* Absence of clinical evidence of nerve root or spinal cord compression at the injury level.
* Degree of spinal canal space narrowing less than 50% based on CT scans.
* Informed consent to participate in the study.
Exclusion Criteria
* Vertebral bone density at the injury level less than 100 HU or osteoporosis exceeding grade 3 in vertebral bodies, pelvic bones, and limbs.
* Previous spinal surgeries.
* Anesthesia risk of 4 or 5 according to ASA.
* Acute exacerbation and decompensation of somatic diseases.
* Malignant tumors at any site.
* Systemic connective tissue disorders.
* Cognitive impairments hindering patient communication.
* Floating and mural thrombosis, regardless of location.
* Newly identified and uncorrectable cardiac rhythm disorders.
* Dizziness.
* Consequences of a previous acute cerebrovascular event.
* Pregnancy at any stage.
* Acute infectious diseases.
* History of fractures of the pelvis, lower limbs, or vertebral bodies.
* Congenital spinal and limb disorders.
* Any conditions contraindicating physiotherapeutic procedures.
* Patient refusal to participate in the study.
* Inability to participate in follow-up examinations for one year after the injury.
* Participation in other clinical trials.
* Absence of a signed informed voluntary consent for medical interventions and processing of personal data or personal data processing.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sklifosovsky Institute of Emergency Care
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ivan Lvov, MD, PhD
neurosurgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrey Grin, MD, PhD
Role: STUDY_CHAIR
Sklifosovsky Research Institute for Emergency Medicine
Aleksandr Talypov, MD, PhD
Role: STUDY_DIRECTOR
Sklifosovsky Research Institute for Emergency Medicine
Vasiliy Karanadze, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Sklifosovsky Research Institute for Emergency Medicine
Ivan Lvov, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Sklifosovsky Research Institute for Emergency Medicine
Anton Kordonskiy, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Sklifosovsky Research Institute for Emergency Medicine
Iren Pogonchenkova, MD, PhD
Role: STUDY_CHAIR
Moscow Scientific and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sklifosovsky Research Institute for Emergency Medicine
Moscow, , Russia
Moscow Scientific and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-28-08/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.